secwatch / observer
8-K filed May 29, 2026, 4:10 PM ET ticker BNTC CIK 0001808898
leadership confidence high sentiment neutral materiality 0.30

Benitec Biopharma appoints David Friedman to board; Megan Boston resigns as director but remains CFO

Benitec Biopharma Inc.

item 5.02

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-26-248289
form_type
8-K
ticker
BNTC
cik
0001808898
company_name
Benitec Biopharma Inc.
filed_at
2026-05-29T20:10:56+00:00
discovered_at
2026-05-29T20:12:01.456946+00:00
generated_at
2026-05-29T20:12:08.351904+00:00
sec_items
["5.02"]
event_type
leadership
sentiment
neutral
materiality_score
0.3
calibrated_materiality_score
0.3
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-26-248289
json_url
https://secwatch.observer/filing/0001193125-26-248289.json
markdown_url
https://secwatch.observer/filing/0001193125-26-248289.md
text_url
https://secwatch.observer/filing/0001193125-26-248289.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/0001193125-26-248289-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1808898/000119312526248289/bntc-20260522.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Megan Boston

Director
BNTC · Benitec Biopharma Inc.
Effective
2026-05-22
Filed
May 29, 2026, 4:10 PM ET
On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.
Appointed

David Friedman

Director
BNTC · Benitec Biopharma Inc.
Effective
2026-05-22
Filed
May 29, 2026, 4:10 PM ET
On May 22, 2026, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed David Friedman to serve as a director of the Board, effective as of such date.

Source-grounded claims

46992999b3

Megan Boston resigned as Director at Benitec Biopharma Inc..

On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

d65cc0a1f2

David Friedman was appointed as Director at Benitec Biopharma Inc..

On May 22, 2026, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed David Friedman to serve as a director of the Board, effective as of such date.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

MZYX

MOZAYYX Acquisition appoints Emma Rose Bienvenu as independent director

MOZAYYX Acquisition Corp. June 1, 2026, 5:00 PM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.

Comparable filing

On May 26, 2026, the Board of Directors (the “ Board ”) of MOZAYYX Acquisition Corp. (the “ Company ”) appointed Emma Rose Bienvenu to serve as an independent director of the Company, effective immediately.

Filing page SEC filing

JOB

Darla Moore resigns from GEE Group board effective June 1, 2026, due to other commitments

GEE Group Inc. June 1, 2026, 4:47 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.

Comparable filing

On June 1, 2026, GEE Group Inc. (the “Company”) (NYSE American: JOB) issued a press release announcing that Ms. Darla Moore, has resigned as a member of the Board of Directors (the “Board”) and from all committees of the Company’s Board effective June 1, 2026, due to the time requirements necessary for her existing and new business commitments.

Filing page SEC filing

SERA

Sera Prognostics director Jeff Elliott resigns ahead of annual meeting

SERA PROGNOSTICS, INC. June 1, 2026, 4:44 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.

Comparable filing

Jeffrey T. Elliott, a member of the Board of Directors (the “Board”) of Sera Prognostics, Inc. (the “Company”), notified the Company of his decision to resign from the Board effective as of June 4, 2026

Filing page SEC filing

FTI

TechnipFMC appoints Eric D. Mullins to Board of Directors effective June 1, 2026

TechnipFMC plc June 1, 2026, 4:38 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.

Comparable filing

the Board elected Eric Mullins to the Board and appointed Mr. Mullins to the Audit Committee of the Board, effective June 1, 2026.

Filing page SEC filing

MCRB

Seres Therapeutics board member Hans-Juergen Woerle resigns, effective May 31, 2026

Seres Therapeutics, Inc. June 1, 2026, 4:30 PM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.

Comparable filing

On May 30, 2026, Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a member of the board of directors of Seres Therapeutics, Inc. (the “Company”) and on the committees on which he serves, effective May 31, 2026.

Filing page SEC filing

MCHP

Microchip appoints former SVP Mitch Little to board, effective June 1, 2026

MICROCHIP TECHNOLOGY INC June 1, 2026, 4:18 PM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.

Comparable filing

appointed Mitch Little, former Senior Vice President, Worldwide Client Engagement of Microchip, as a member of the Board, effective June 1, 2026.

Filing page SEC filing

PUMP

Director Alex Volkov resigns from ProPetro board after Pioneer (Exxon) sells all shares

ProPetro Holding Corp. June 1, 2026, 4:16 PM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.

Comparable filing

On May 28, 2026, ProPetro Holding Corp. (the “Company”) announced the resignation of Alex V. Volkov from the Company’s Board of Directors (the “Board”).

Filing page SEC filing

DE

Deere director Dmitri Stockton will not seek re-election at 2027 annual meeting

DEERE & CO June 1, 2026, 4:15 PM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.

Comparable filing

On May 26, 2026, Dmitri Stockton notified the Board of Directors (the “Board”) of Deere & Company (the “Company”) that he would not stand for re-election as a director at the 2027 annual meeting of stockholders.

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-26-248289
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.